BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27163689)

  • 1. Influence of hemorheological factors on the development of retinal vein occlusion.
    Michalska-Małecka K; Śpiewak D; Słowińska-Łożyńska L; Sierocka-Stępień J
    Clin Hemorheol Microcirc; 2016 May; 63(1):69-76. PubMed ID: 27163689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
    Lip PL; Blann AD; Jones AF; Lip GY
    Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion.
    Becatti M; Marcucci R; Gori AM; Mannini L; Grifoni E; Alessandrello Liotta A; Sodi A; Tartaro R; Taddei N; Rizzo S; Prisco D; Abbate R; Fiorillo C
    J Thromb Haemost; 2016 Nov; 14(11):2287-2297. PubMed ID: 27557753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
    Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
    JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of haemorheological factors in patients with retinal vein occlusion.
    Sofi F; Mannini L; Marcucci R; Bolli P; Sodi A; Giambene B; Menchini U; Gensini GF; Abbate R; Prisco D
    Thromb Haemost; 2007 Dec; 98(6):1215-9. PubMed ID: 18064316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution.
    Wiek J; Schade M; Wiederholt M; Arntz HR; Hansen LL
    Br J Ophthalmol; 1990 Nov; 74(11):665-9. PubMed ID: 2223704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced central retinal vein thrombosis: possible involvement of hemorheological disturbances. A case report.
    Gaudard A; Varlet-Marie E; Monnier JF; Janbon Ch; Quéré I; Bressolle F; Brun JF
    Clin Hemorheol Microcirc; 2002; 27(2):115-22. PubMed ID: 12237481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials.
    Thach AB; Yau L; Hoang C; Tuomi L
    Ophthalmology; 2014 May; 121(5):1059-66. PubMed ID: 24424249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].
    Glacet-Bernard A; Coscas G; Lelong F; Chabanel A; Samama M; Taccoen A
    Bull Soc Ophtalmol Fr; 1989 Dec; 89(12):1393-6. PubMed ID: 2632113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials.
    Varma R; Bressler NM; Suñer I; Lee P; Dolan CM; Ward J; Colman S; Rubio RG;
    Ophthalmology; 2012 Oct; 119(10):2108-18. PubMed ID: 22817833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Dexamethasone Implant on Rheological Blood Parameters in Patients Treated for Retinal Vein Thrombosis.
    Śpiewak D; Heinke A; Michalska-Małecka K
    Int J Gen Med; 2022; 15():6931-6944. PubMed ID: 36065219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increase of erythrocyte aggregation in retinal vein occlusion].
    Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
    J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANIBIZUMAB FOR RETINAL VEIN OCCLUSION: Predictive Factors and Long-Term Outcomes in Real-Life Data.
    Chatziralli I; Theodossiadis G; Chatzirallis A; Parikakis E; Mitropoulos P; Theodossiadis P
    Retina; 2018 Mar; 38(3):559-568. PubMed ID: 28248827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
    Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
    Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Singer MA; Capone A; Dugel PU; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Apr; 15():33. PubMed ID: 25885285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
    Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.